Published: May 16, 2026 · Last updated: May 16, 2026
- Roughly 15 million Americans take proton pump inhibitors daily, often for years longer than the original prescription intended (Harvard Health, 2024)
- PPIs reduce calcium absorption, which is linked to a higher risk of hip and spine fractures in long-term users, especially adults over 50 (Cleveland Clinic, 2024)
- Recent large studies have softened the earlier dementia-risk signal, but newer observational data still associate long-term PPI use with chronic kidney disease and B12 deficiency (Harvard Health, 2024)
You started a PPI for heartburn after a stressful stretch at work. The plan was 8 weeks. That was 6 years ago. Refills appeared automatically. The pharmacist never asked why. Your doctor never raised it. It just kept happening, the way comfortable medications often do.
PPIs (omeprazole, esomeprazole, pantoprazole, lansoprazole, and the rest) are some of the most-prescribed drugs in America for a reason: they work, they are cheap, and they are well tolerated in the short term. The concern is not whether they are useful. The concern is what 5, 10, or 15 years of continuous acid suppression does to absorption, bone, kidney, and possibly cognition. The honest answer in 2026 is that some of the early alarms have softened, but several real signals remain.
Why The Long-Term Conversation Even Started
Stomach acid does more than digest food. It helps absorb calcium, magnesium, iron, and vitamin B12. It also acts as a barrier against bacteria that would otherwise pass into the small intestine. Suppress acid for years and downstream effects on absorption and gut flora are biologically plausible, even before any specific study is run.
That plausibility, plus a wave of observational studies in the 2010s, raised concerns about bone fractures, kidney disease, dementia, certain pneumonias, and a stubborn intestinal infection called C. difficile. The FDA added label warnings about fracture risk and low magnesium in 2010 and 2011. The conversation moved from "completely safe" to "use the lowest dose for the shortest time clinically reasonable" (Harvard Health, 2024).
What The Evidence Now Says About Bones
The bone signal is the most consistent in the literature. Multiple studies show a small but real increase in hip and spine fracture risk in long-term PPI users, particularly adults over 50 already at risk for osteoporosis. The biological story fits: less stomach acid means less calcium absorbed from food, even if calcium intake on paper looks adequate.
For someone on a PPI for 5+ years with other osteoporosis risk factors (postmenopausal status, low body weight, family history, prior fracture, smoking), the practical move is to confirm a recent DEXA scan, optimize calcium and vitamin D intake, and have a candid conversation about whether the PPI is still needed at the current dose (Cleveland Clinic, 2024).
Kidneys, B12, And The Quiet Effects
Observational data link long-term PPI use to a modest increased risk of chronic kidney disease and acute kidney injury. The mechanism is not fully understood, but the association persists across multiple large cohorts. The absolute risk for any individual is small, but over 10 to 15 years of continuous use, it adds up.
Vitamin B12 deficiency is the most under-discussed effect. PPIs reduce acid release that is needed to free B12 from food proteins. After 2+ years, mild B12 deficiency becomes measurable in roughly 25% of long-term users. Symptoms (fatigue, brain fog, peripheral numbness) often get blamed on aging rather than the drug. A simple blood test catches it. Sublingual or injected B12 corrects it.
What Recent Studies Have Walked Back
The dementia-risk signal that hit headlines in 2016 has not held up cleanly in larger, better-controlled studies. Several recent analyses, including ones that adjusted for confounders the original studies could not, found no significant association between PPI use and dementia. Harvard's most current guidance reflects that softening: the dementia concern is no longer a primary reason to stop a PPI that is medically indicated.
Similarly, the early kidney disease signal has been refined. The association is still present but smaller than the 2016 studies suggested. The right framing now is that long-term PPI use carries a small additional risk profile that becomes meaningful only at long durations and in already-vulnerable patients.
How To Step Down Safely If You No Longer Need It
Stopping a PPI cold turkey often triggers rebound acid hypersecretion. Symptoms feel worse for a couple weeks, which sends people right back to the drug. The taper protocol most gastroenterologists use is to halve the dose every 1 to 2 weeks, then switch to an H2 blocker (famotidine) for a few weeks, then to as-needed antacids. Many people who taper successfully discover they did not actually need daily PPI to begin with.
Lifestyle measures that reduce reflux often substitute well: elevating the head of the bed about 6 inches, avoiding meals within 3 hours of bedtime, weight loss if overweight, and identifying personal trigger foods. None of these is exotic, but together they handle a meaningful percentage of mild-to-moderate reflux without medication.
To your health,
Ageless Coach
Age Strong. Live Long.
Trusted Sources Behind This Article
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.
Frequently Asked Questions
Want one verified-science article like this every week?
Get Better Health, Weekly